I-Mab Biopharma
IMAB
$1.78
Share price
0.56%
Change (1 day)
-43.65%
Change (1 year)
Categories
I-Mab Biopharma (IMAB) - Total liabilities
Total liabilities on the balance sheet as of June 2023 : $0.14 B
According to I-Mab Biopharma's latest financial reports the company's total liabilities are $0.14 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
I-Mab Biopharma - Total liabilities on balance sheet (from 2018 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $0.16 B | 3.22% |
| 2021-12-31 | $0.16 B | 50.88% |
| 2020-12-31 | $0.10 B | -79.94% |
| 2019-12-31 | $0.53 B | 11.49% |
| 2018-12-31 | $0.48 B | 137.79% |
| 2017-12-31 | $0.20 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | $0.62 B | 323.89% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | $12.01 M | -91.82% | 🇺🇸 USA |